e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Macrophages: cell biology and disease-specific characteristics
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Phenotype polarization of alveolar macrophages in COPD patients
F. Polverino, S. Baraldo, M. Cosio, M. Saetta, A. Agusti, J. Sauleda, B. Cosio (Cava dei Tirreni, Padova, Italy; Palma de Mallorca, Barcelona, Spain)
Source:
Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Session:
Macrophages: cell biology and disease-specific characteristics
Session type:
Thematic Poster Session
Number:
4346
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Polverino, S. Baraldo, M. Cosio, M. Saetta, A. Agusti, J. Sauleda, B. Cosio (Cava dei Tirreni, Padova, Italy; Palma de Mallorca, Barcelona, Spain). Phenotype polarization of alveolar macrophages in COPD patients. Eur Respir J 2010; 36: Suppl. 54, 4346
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Expression of surface receptors on alveolar macrophages and monocytes from patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 453s
Year: 2004
Reduced haemeoxygenase-1 immunoreactivity in alveolar macrophages in severe COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001
Change of phenotype and phenotypic plasticity of alveolar macrophages in COPD
Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Year: 2012
Increased haemosiderin-laden alveolar macrophages in IPF patients
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Assessment of the phagocytic capability of sputum macrophages and neutrophils in COPD patients.
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Stability of housekeeping genes in alveolar macrophages from COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 94s
Year: 2005
No evidence of corticosteroid resistance in COPD alveolar macrophages
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009
Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002
Alveolar macrophage size is increased in COPD patients compared to controls
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Source: Eur Respir J 2006; 28: 486-495
Year: 2006
Antiinflammatory effects of formoterol in macrophages as a model for alveolar macrophages in COPD
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008
Glucocorticoid sensitivity of LPS stimulated COPD alveolar macrophages
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Activated neutrophils are increased in bronchial biopsies from patients with severe COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 718s
Year: 2004
Expansion of alveolar-lymphoid interfaces in lungs of patients with COPD
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Colony stimulating factors cannot correct defective phagocytosis in COPD lung tissue macrophages
Source: International Congress 2016 – Airway response to infection
Year: 2016
Differential regulation of inflammatory pathways in alveolar macrophages from COPD patients and smoking controls
Source: Annual Congress 2007 - Novel mediators of cellular pathology
Year: 2007
Reduced expression of CD44 on lung macrophages from patients with COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept